资源描述：
《gx-lshc-2016-life-sciences-outlook》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、2016GloballifesciencesoutlookMovingforwardwithcautiousoptimism2016Globallifesciencesoutlook
2、Movingforwardwithcautiousoptimism1OverviewandoutlookThelifesciencesindustryhasfaredwellinpasteconomicEnteringthesecondhalfofthisdecade,mostlifesciencesrecessionsbuthowisitperforminginto
3、day’svolatileorganizationsappeartobeadoptinganattitudeofcautiousmarketplace,onecharacterizedbyeconomicuncertainty,optimism.Significantopportunitiesexistintheglobalreform-drivenpricingpressures,increaseddemandformarketplacebutchallengesexist,aswell.Spendinggrowthinnovationandva
4、lue,morefocusontheconsumerandinpharmaceuticals(pharma),biotechnology(biotech),consumerengagement,andanever-changingregulatoryandandmedicaltechnologies(medtech)isprojectedtofollowriskenvironment?anupwardtrendduetoincreasingdemand,butpricingchallengesarestillanissue.Industrymarg
5、insarebeingThelifesciencessector’sgrowthcorrelateshighlywitherodedbyhighdiscounts,retailsectorpricecontrols,publiccountries’generaleconomicstrengthandhealthcaresectorpurchasingpolicies,andthemovetovalue-basedspendinglevels,andbothofthesevarywidelyaroundthecare.Strongeconomicgr
6、owthlookshardtocomebyinglobe.TheEconomistIntelligenceUnit(EIU)reportsthatmanycountries;therefore,assumptionsonhealthspendinghealthcarespendinginthe60countriesthatitcoversrosemayneedtobereviseddownward.Inresponsetotoday’sby2.6percentinnominalU.S.dollartermsin2014butthatdynamica
7、llychangingclinical,regulatory,andbusinessspendingisforecastedtodipin2015,reflectingthecurrentlandscape,pharma,biotech,andmedtechcompaniesweaknessoftheeuroandothercurrenciesagainsttheU.S.arere-evaluatingandadaptingtraditionalresearchanddollar.1Andwhilespendinggrowthisexpectedt
8、opickupdevelopment(R&D),pricing,supplychain,andcommercialbeginningin2016,thepressuretoreducecosts,increasemodels.efficiency,andprovevalueremainsintense.Becauseofthesecontradictorytrends,globalhealthcarespendingisexpectedThis2016globaloutlookreviewsthecurrentstateofthetoincreas
9、ebyonlyanaverageof4.3percentin2015-2019,lifesciencessector;ex
